Swiss Health Care | Switzerland Secrets To Longevity

Salud

Groupe Mutuel Might Leave Santésuisse

Groupe Mutuel's CEO Thomas Boyer discusses the possibility of leaving Santésuisse, advocating for unity in health associations for the benefit of premium payers.

Helpany Expands to the USA: A New Chapter in Senior Care Innovation

Swiss startup Helpany sets its sights on the US, bringing its advanced AI-driven senior care solution to new markets in Spring 2024.

Zurich Research AI

La IA de la investigación de Zúrich: detecta defectos cardíacos

13 de marzo de 2024

Investigadores de Zúrich desarrollan una IA para detectar la hipertensión pulmonar en recién nacidos, lo que permite esperar un diagnóstico precoz y mejores resultados.

Sandoz Forecasts Growth and Increased Margins in 2024

13 de marzo de 2024

Sandoz, now an independent entity, celebrates a year of growth, setting sights on heightened sales and margins for 2024.

Fuga de gas natural en Rotkreuz ZG: 15 residentes evacuados

9 de marzo de 2024

En Rotkreuz ZG, una fuga de gas tras un accidente de perforación provocó una rápida evacuación.

Digitalising Healthcare

Switzerland Will Spend CHF 400 Million on Digitalising Healthcare

7 de marzo de 2024

Switzerland's National Council greenlights the CHF 400 million Digisanté program to advance healthcare digitalisation, amid calls for vigilant oversight.

Alcon

Alcon aspira a facturar $12.000 millones en 2027

6 de marzo de 2024

Alcon aims for growth with a $12 billion revenue target by 2027, post-Novartis spin-off.

Swiss Health Care Sector Shortage: Spitex Launch Campaign

4 de marzo de 2024

Switzerland faces a critical healthcare worker shortfall, with an urgent need for new entrants, spurring nationwide recruitment efforts.

Zambon Group

Zambon Group: Exclusive Licensing Deal for IPX203 in Europe

29 febrero 2024

Keystone/SDA - DARRON CUMMINGS Amneal Pharmaceuticals, aligning with Zambon Group, announces an exclusive licensing pact for IPX203 in key European regions.

Swiss biotech

La biotecnológica suiza Idorsia: sus acciones se disparan, pero ¿por qué?

26 febrero 2024

Idorsia's Surging Stock: Speculations Amid Silence Keystone/SDA - GEORGIOS KEFALAS Swiss biotech firm Idorsia, based in Basel, has seen a spike in stock prices from just $2.

El CSEM se une a ClexBio para luchar contra los problemas cardiovasculares

26 febrero 2024

El CSEM se asocia con el innovador nórdico ClexBio para ser pionero en un biorreactor, un salto en las venas humanas cultivadas en laboratorio para la medicina regenerativa.

Social Democrats Health Insurance Initiative Fails

24 febrero 2024

Swiss Center Rejects Health Premium Cap Proposal, Debates Cost and Solidarity in Healthcare Keystone/SDA - PETER SCHNEIDER The Center rejects the SP's premium relief initiative.

Alys Pharmaceuticals se lanza con $100M de Medicxi

21 febrero 2024

Alys Pharmaceuticals, the immuno-dermatology trailblazer with a $100M boost from Medicxi.

Swissmedic

Swissmedic Approves New Drugs Against Cancer

12 febrero 2024

Swissmedic's latest approvals spotlight oncology with ten new cancer drugs leading the charge.

Swiss Breakthrough: Halting Ageing in Mice with Novel Drug

Swiss researchers achieve a milestone in anti-ageing research by successfully slowing down the ageing process in mice, opening new avenues for human health advancements.

Advertencia pública: Residuos de plaguicidas en los tomates secos de Ceposa AG

Ceposa AG descubre el pesticida nocivo clorpirifos-etil en tomates secos, lo que supone un riesgo potencial para la salud.

Fribourg Cantonal Hospital Receives 175M CHF from the State

The Fribourg Cantonal Hospital is set for a financial revival with a 175 million francs boost from the state, marking a significant step towards addressing its prolonged financial woes.

New Slimming Products Could Drive Costs up in the Healthcare Sector

GLP-1 Drugs: A Costly Revolution in Obesity Treatment. Drugs with a punch like the new GLP-1 drugs inevitably lead to discussions about their cost.

Historias relacionadas

Mantente en contacto

Cabe destacar

Una producción de UltraSwiss AG, 6340 Baar, Suiza

Enlaces rápidos

Inicio Privacidad GTC Póngase en contacto con nosotros Quiénes somos

Copyright © 2024 UltraSwiss AG 2024 Todos los derechos reservados